TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Instagram Outage Disrupts Thousands of U.S. Users 
Erik Dowell was appointed as Chief Executive Officer of the Americas for InMode
IRVINE, Calif., Jan. 25, 2017 -- InMode/Invasix, a rapidly expanding professional aesthetic device company, announced Erik Dowell as Chief Executive Officer of the Americas. Mr. Dowell assumes leadership of the company’s North & South American sales, marketing, service, logistics and finance.
Moshe Mizrahy, CEO of InMode International Division, comments: “Erik is a veteran in the medical aesthetic industry and I am sure that he will bring with him many new ideas and lots of energy to continue our momentum in the market.”
Prior to that, Mr. Dowell served as President of the Americas with Syneron Candela since July 2013. With over 18 years of experience in the aesthetic light-based industry, Mr. Dowell held several positions within the company, including Vice President of the EMEA region (2010 - July 2013), Vice President of North America (2007-2010) and Regional Sales Director in North America (2003-2007). Prior to working for Syneron, Mr. Dowell worked for Coherent/Lumenis laser company from 1999 serving as the Western Regional Manager. Mr. Dowell received a B.A. in Business Management from University of Phoenix. He also completed the Executive Education Programs at the University of Chicago, and Harvard Business School (Harvard University).
About InMode/Invasix
InMode’s technological advancements have become the new standard for aesthetic medicine, specifically in the radio-frequency aesthetic market. For more than three decades our R&D team was critical in developing state-of-the-art light, laser, and radio-frequency devices, thereby launching and shaping the industry. Our technology continues that legacy in providing superior satisfaction for both the patient and the practice. Learn more about InMode/Invasix technologies by visiting www.inmodemd.com.
Contact: Yang Phan Vice-President of Marketing for North America [email protected] | 1.855.411.2639 x3
